PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer.
Suresh S, Huard S, Brisson A, Némati F, Dakroub R, Poulard C, Ye M, Martel E, Reyes C, Silvestre DC, Meseure D, Nicolas A, Gentien D, Fayyad-Kazan H, Le Romancer M, Decaudin D, Roman-Roman S, Dubois T.
Suresh S, et al. Among authors: dakroub r.
Cancers (Basel). 2022 Jan 8;14(2):306. doi: 10.3390/cancers14020306.
Cancers (Basel). 2022.
PMID: 35053470
Free PMC article.